AstraZeneca PLC (AZNCF) Stock Overview
Explore AstraZeneca PLC’s financial performance, market position, analyst ratings, and future outlook.
AstraZeneca PLC (AZNCF)
Key Financials
Key Financials
Market Cap
294.4B
P/E Ratio
28.60
EPS (TTM)
$6.03
ROE
0.23%
AZNCF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of AstraZeneca PLC (AZNCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 66.25, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $174.35.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.60 and a market capitalization of 294.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.